Difference between revisions of "Talk:20.109(S16):Flow cytometry and paper discussion (Day7)"
From Course Wiki
Noreen Lyell (Talk | contribs) (→Tables for group data:) |
(→WF section) |
||
(26 intermediate revisions by 12 users not shown) | |||
Line 4: | Line 4: | ||
[[Media:Sp16 FlowCytometry SampleKey Instructors.xlsx| Instructor FC sample key]] | [[Media:Sp16 FlowCytometry SampleKey Instructors.xlsx| Instructor FC sample key]] | ||
+ | |||
+ | [[Media:Sp16 Instructor FC plots 160404.pdf| Instructor FC plots]] | ||
+ | |||
+ | [[Media:Sp16 Instructor FC Spreadsheet 160405.xlsx| Instructor FC spreadsheet]] | ||
====Student samples==== | ====Student samples==== | ||
Line 21: | Line 25: | ||
===Tables for group data:=== | ===Tables for group data:=== | ||
− | <font color = red> Report both the median and mean calculations within the table according to the following format: median value, mean value </font color = red> | + | <font color = red> '''Report both the median and mean calculations for each replicate within the table according to the following format: median value, mean value''' </font color = red> |
====TR section==== | ====TR section==== | ||
− | TR Red Team: '''( | + | TR Red Team: '''(EcoRI, BGlII, DMNB)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 32: | Line 36: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |2.2, 1.9 |
− | | | + | |2.4, 3.0 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.4, 2.2 |
− | | | + | |1.9, 1.0 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |3.0, 3.0 |
− | | | + | |2.9, 2.8 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.11, 0.05 |
− | | | + | |0.13, 0.12 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.17, 0.27 |
− | | | + | |0.04, 0.05 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0, 0 |
− | | | + | |0, 0 |
|- | |- | ||
|} | |} | ||
Line 59: | Line 63: | ||
− | TR Orange Team: '''( | + | TR Orange Team: '''(PmeI and DMNB)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 67: | Line 71: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |2.09, 1.77 |
− | | | + | |2.54, 2.60 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |3.04, 1.95 |
− | | | + | |2.58, 3.49 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |4.11, 2.09 |
− | | | + | |2.70, 1.65 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.24, 0.21 |
− | | | + | |0.21, 0.13 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.07, 0.08 |
− | | | + | |0.18, 0.21 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.01, 0.03 |
− | | | + | |0.04, 0.02 |
|- | |- | ||
|} | |} | ||
Line 94: | Line 98: | ||
− | TR Yellow Team: '''( | + | TR Yellow Team: '''(BglII PstI DMNB)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 102: | Line 106: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |2.4, 2.4 |
− | | | + | |2.2, 2.6 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.2, 2.2 |
− | | | + | |2.4, 2.8 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |3.2, 3.0 |
− | | | + | |2.6, 2.2 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.18, 0.15 |
− | | | + | |0.18, .18 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.19, 0.61 |
− | | | + | |0.025, 0.030 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0 |
− | | | + | |0 |
|- | |- | ||
|} | |} | ||
Line 129: | Line 133: | ||
− | TR Green Team: '''( | + | TR Green Team: '''(PmeI and Loperamide)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 137: | Line 141: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |3.03, 2.26 |
− | | | + | |2.44, 2.34 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.88, 2.07 |
− | | | + | |3.05, 2.20 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.07, 3.01 |
− | | | + | |1.75, 2.12 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.25, 0.24 |
− | | | + | |0.19, 0.34 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.12, 0.31 |
− | | | + | |0.16, 0.29 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.05, 0.02 |
− | | | + | |0, 0 |
|- | |- | ||
|} | |} | ||
Line 164: | Line 168: | ||
− | TR Blue Team: '''( | + | TR Blue Team: '''(EcoRI + BglII - Loperamide)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 172: | Line 176: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |2.252,2.358 |
− | | | + | |2.422,2.271 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.088,2.223 |
− | | | + | |1.758,2.218 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.847,3.344 |
− | | | + | |2.560,3.024 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.104,0.085 |
− | | | + | |0.146,0.204 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.133,0.109 |
− | | | + | |0.087,0.114 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.005,0.002 |
− | | | + | |0.079,0.037 |
|- | |- | ||
|} | |} | ||
Line 199: | Line 203: | ||
− | TR Pink Team: ''' | + | TR Pink Team: '''EcoRI-BglII DMNB''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 207: | Line 211: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |1.93, 2.21 |
− | | | + | |2.97, 2.39 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.20, 2.38 |
− | | | + | |0.98, 1.92 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.92, 2,96 |
− | | | + | |2.79, 2.90 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.05, 0.11 |
− | | | + | |0.11, 0.13 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.27, 0.17 |
− | | | + | |0.05, 0.03 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0, 0 |
− | | | + | |0,0 |
|- | |- | ||
|} | |} | ||
Line 234: | Line 238: | ||
− | TR Purple Team: ''' | + | TR Purple Team: '''PmeI DMNB''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 242: | Line 246: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |1.772724608, 2.085453242 |
− | | | + | |2.600281239, 2.537742473 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |1.948901491, 3.044622474 |
− | | | + | |3.487826161, 2.579098259 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.092658688, 4.11618439 |
− | | | + | |1.651441549, 2.700436438 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.207545736, 0.240272044 |
− | | | + | |0.133947935, 0.214451077 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.084415562, 0.074686032 |
− | | | + | |0.208750497, 0.175961141 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.026551063, 0.011684889 |
− | | | + | |0.015829439, 0.04141871 |
|- | |- | ||
|} | |} | ||
Line 270: | Line 274: | ||
====WF section==== | ====WF section==== | ||
− | WF Red Team: ''' | + | WF Red Team: '''BglII & PstI, Loperamide''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 278: | Line 282: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |1.9, 2.2 |
− | | | + | |2.25, 2.28 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.88, 2.59 |
− | | | + | |2.77, 2.25 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.97, 3.75 |
− | | | + | |1.71, 2.4 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.11, 0.12 |
− | | | + | |0.1, 0.14 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.09, 0.09 |
− | | | + | |0.07, 0.06 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.04, 0.02 |
− | | | + | |0.02, 0.01 |
|- | |- | ||
|} | |} | ||
Line 305: | Line 309: | ||
− | WF Orange Team: ''' | + | WF Orange Team: ''' ECORI + BglII - Loperamide''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 313: | Line 317: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |2.25, 2.36 |
− | | | + | |2.42, 2.27 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.09, 2.22 |
− | | | + | |1.76, 2.22 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.85, 3.34 |
− | | | + | |2.56, 3.02 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.10, 0.09 |
− | | | + | |0.15, 0.20 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.13, 0.11 |
− | | | + | |0.09, 0.11 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.01, 0.00 |
− | | | + | |0.08, 0.04 |
|- | |- | ||
|} | |} | ||
Line 340: | Line 344: | ||
− | WF Blue Team: '''( | + | WF Blue Team: '''(PmeI Loperamide)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 348: | Line 352: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |3.02, 2.25 |
− | | | + | |2.43, 2.34 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.88, 2.07 |
− | | | + | |3.05, 2.20 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.06, 3.1 |
− | | | + | |1.75,2.12 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.254, 0.241 |
− | | | + | |0.19, 0.33 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.12, 0.31 |
− | | | + | |0.16, 0.29 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.05, 0.02 |
− | | | + | |0, 0 |
|- | |- | ||
|} | |} | ||
Line 375: | Line 379: | ||
− | WF Pink Team: '''( | + | WF Pink Team: '''(PstI & BglII, Loperamide)''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 383: | Line 387: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |1.90, 2.20 |
− | | | + | |2.25, 2.28 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.88, 2.59 |
− | | | + | |2.77, 2.25 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |2.97, 3.75 |
− | | | + | |1.71, 2.40 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.11, 0.12 |
− | | | + | |0.10, 0.14 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.09, 0.09 |
− | | | + | |0.07, 0.06 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0.04, 0.02 |
− | | | + | |0.02, 0.01 |
|- | |- | ||
|} | |} | ||
Line 410: | Line 414: | ||
− | WF Purple Team: ''' | + | WF Purple Team: '''PstI-BglII, DMNB''' |
<center> | <center> | ||
{| border="1" | {| border="1" | ||
Line 418: | Line 422: | ||
|- | |- | ||
|M059K mCherry:EGFP | |M059K mCherry:EGFP | ||
− | | | + | |2.42, 2.43 |
− | | | + | |2.21, 2.58 |
|- | |- | ||
|M059K mCherry:EGFP + drug | |M059K mCherry:EGFP + drug | ||
− | | | + | |2.21, 2.20 |
− | | | + | |2.38, 2.79 |
|- | |- | ||
|M059J mCherry:EGFP | |M059J mCherry:EGFP | ||
− | | | + | |3.20, 2.99 |
− | | | + | |2.59, 2.20 |
|- | |- | ||
|M059K mCherry:damaged EGFP | |M059K mCherry:damaged EGFP | ||
− | | | + | |0.18, 0.15 |
− | | | + | |0.18, 0.18 |
|- | |- | ||
|M059K mCherry:damaged EGFP + drug | |M059K mCherry:damaged EGFP + drug | ||
− | | | + | |0.19, 0.61 |
− | | | + | |0.03, 0.03 |
|- | |- | ||
|M059J mCherry:damaged EGFP | |M059J mCherry:damaged EGFP | ||
− | | | + | |0, 0 |
− | | | + | |0, 0 |
|- | |- | ||
|} | |} | ||
</center> | </center> |
Latest revision as of 04:54, 13 April 2016
Contents
Files to download for analysis:
Instructor samples
Student samples
Tables for group data:
Report both the median and mean calculations for each replicate within the table according to the following format: median value, mean value
TR section
TR Red Team: (EcoRI, BGlII, DMNB)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 2.2, 1.9 | 2.4, 3.0 |
M059K mCherry:EGFP + drug | 2.4, 2.2 | 1.9, 1.0 |
M059J mCherry:EGFP | 3.0, 3.0 | 2.9, 2.8 |
M059K mCherry:damaged EGFP | 0.11, 0.05 | 0.13, 0.12 |
M059K mCherry:damaged EGFP + drug | 0.17, 0.27 | 0.04, 0.05 |
M059J mCherry:damaged EGFP | 0, 0 | 0, 0 |
TR Orange Team: (PmeI and DMNB)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 2.09, 1.77 | 2.54, 2.60 |
M059K mCherry:EGFP + drug | 3.04, 1.95 | 2.58, 3.49 |
M059J mCherry:EGFP | 4.11, 2.09 | 2.70, 1.65 |
M059K mCherry:damaged EGFP | 0.24, 0.21 | 0.21, 0.13 |
M059K mCherry:damaged EGFP + drug | 0.07, 0.08 | 0.18, 0.21 |
M059J mCherry:damaged EGFP | 0.01, 0.03 | 0.04, 0.02 |
TR Yellow Team: (BglII PstI DMNB)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 2.4, 2.4 | 2.2, 2.6 |
M059K mCherry:EGFP + drug | 2.2, 2.2 | 2.4, 2.8 |
M059J mCherry:EGFP | 3.2, 3.0 | 2.6, 2.2 |
M059K mCherry:damaged EGFP | 0.18, 0.15 | 0.18, .18 |
M059K mCherry:damaged EGFP + drug | 0.19, 0.61 | 0.025, 0.030 |
M059J mCherry:damaged EGFP | 0 | 0 |
TR Green Team: (PmeI and Loperamide)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 3.03, 2.26 | 2.44, 2.34 |
M059K mCherry:EGFP + drug | 2.88, 2.07 | 3.05, 2.20 |
M059J mCherry:EGFP | 2.07, 3.01 | 1.75, 2.12 |
M059K mCherry:damaged EGFP | 0.25, 0.24 | 0.19, 0.34 |
M059K mCherry:damaged EGFP + drug | 0.12, 0.31 | 0.16, 0.29 |
M059J mCherry:damaged EGFP | 0.05, 0.02 | 0, 0 |
TR Blue Team: (EcoRI + BglII - Loperamide)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 2.252,2.358 | 2.422,2.271 |
M059K mCherry:EGFP + drug | 2.088,2.223 | 1.758,2.218 |
M059J mCherry:EGFP | 2.847,3.344 | 2.560,3.024 |
M059K mCherry:damaged EGFP | 0.104,0.085 | 0.146,0.204 |
M059K mCherry:damaged EGFP + drug | 0.133,0.109 | 0.087,0.114 |
M059J mCherry:damaged EGFP | 0.005,0.002 | 0.079,0.037 |
TR Pink Team: EcoRI-BglII DMNB
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 1.93, 2.21 | 2.97, 2.39 |
M059K mCherry:EGFP + drug | 2.20, 2.38 | 0.98, 1.92 |
M059J mCherry:EGFP | 2.92, 2,96 | 2.79, 2.90 |
M059K mCherry:damaged EGFP | 0.05, 0.11 | 0.11, 0.13 |
M059K mCherry:damaged EGFP + drug | 0.27, 0.17 | 0.05, 0.03 |
M059J mCherry:damaged EGFP | 0, 0 | 0,0 |
TR Purple Team: PmeI DMNB
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 1.772724608, 2.085453242 | 2.600281239, 2.537742473 |
M059K mCherry:EGFP + drug | 1.948901491, 3.044622474 | 3.487826161, 2.579098259 |
M059J mCherry:EGFP | 2.092658688, 4.11618439 | 1.651441549, 2.700436438 |
M059K mCherry:damaged EGFP | 0.207545736, 0.240272044 | 0.133947935, 0.214451077 |
M059K mCherry:damaged EGFP + drug | 0.084415562, 0.074686032 | 0.208750497, 0.175961141 |
M059J mCherry:damaged EGFP | 0.026551063, 0.011684889 | 0.015829439, 0.04141871 |
WF section
WF Red Team: BglII & PstI, Loperamide
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 1.9, 2.2 | 2.25, 2.28 |
M059K mCherry:EGFP + drug | 2.88, 2.59 | 2.77, 2.25 |
M059J mCherry:EGFP | 2.97, 3.75 | 1.71, 2.4 |
M059K mCherry:damaged EGFP | 0.11, 0.12 | 0.1, 0.14 |
M059K mCherry:damaged EGFP + drug | 0.09, 0.09 | 0.07, 0.06 |
M059J mCherry:damaged EGFP | 0.04, 0.02 | 0.02, 0.01 |
WF Orange Team: ECORI + BglII - Loperamide
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 2.25, 2.36 | 2.42, 2.27 |
M059K mCherry:EGFP + drug | 2.09, 2.22 | 1.76, 2.22 |
M059J mCherry:EGFP | 2.85, 3.34 | 2.56, 3.02 |
M059K mCherry:damaged EGFP | 0.10, 0.09 | 0.15, 0.20 |
M059K mCherry:damaged EGFP + drug | 0.13, 0.11 | 0.09, 0.11 |
M059J mCherry:damaged EGFP | 0.01, 0.00 | 0.08, 0.04 |
WF Blue Team: (PmeI Loperamide)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 3.02, 2.25 | 2.43, 2.34 |
M059K mCherry:EGFP + drug | 2.88, 2.07 | 3.05, 2.20 |
M059J mCherry:EGFP | 2.06, 3.1 | 1.75,2.12 |
M059K mCherry:damaged EGFP | 0.254, 0.241 | 0.19, 0.33 |
M059K mCherry:damaged EGFP + drug | 0.12, 0.31 | 0.16, 0.29 |
M059J mCherry:damaged EGFP | 0.05, 0.02 | 0, 0 |
WF Pink Team: (PstI & BglII, Loperamide)
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 1.90, 2.20 | 2.25, 2.28 |
M059K mCherry:EGFP + drug | 2.88, 2.59 | 2.77, 2.25 |
M059J mCherry:EGFP | 2.97, 3.75 | 1.71, 2.40 |
M059K mCherry:damaged EGFP | 0.11, 0.12 | 0.10, 0.14 |
M059K mCherry:damaged EGFP + drug | 0.09, 0.09 | 0.07, 0.06 |
M059J mCherry:damaged EGFP | 0.04, 0.02 | 0.02, 0.01 |
WF Purple Team: PstI-BglII, DMNB
Sample | Normalized EGFP/mCherry value (replicate #1) | Normalized EGFP/mCherry value (replicate #2) |
---|---|---|
M059K mCherry:EGFP | 2.42, 2.43 | 2.21, 2.58 |
M059K mCherry:EGFP + drug | 2.21, 2.20 | 2.38, 2.79 |
M059J mCherry:EGFP | 3.20, 2.99 | 2.59, 2.20 |
M059K mCherry:damaged EGFP | 0.18, 0.15 | 0.18, 0.18 |
M059K mCherry:damaged EGFP + drug | 0.19, 0.61 | 0.03, 0.03 |
M059J mCherry:damaged EGFP | 0, 0 | 0, 0 |